RxSight, Inc. (RXST)
4.85
+0.05
(+1.04%)
USD |
NASDAQ |
Oct 08, 16:00
4.85
0.00 (0.00%)
After-Hours: 20:00
RxSight Max Drawdown (5Y) : 92.86% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 92.86% |
| August 31, 2026 | 92.86% |
| July 31, 2026 | 92.86% |
| June 30, 2026 | 92.86% |
| May 31, 2026 | 91.71% |
| April 30, 2026 | 90.53% |
| March 31, 2026 | 90.53% |
| Date | Value |
|---|---|
| February 28, 2026 | 89.66% |
| January 31, 2026 | 89.66% |
| December 31, 2025 | 89.66% |
| November 30, 2025 | 89.66% |
| October 31, 2025 | 89.66% |
| September 30, 2025 | 89.66% |
| August 31, 2025 | 89.66% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| IDEXX Laboratories, Inc. | 54.00% |
| Neogen Corp. | 90.92% |
| QuidelOrtho Corp. | 94.30% |
| Aspira Women's Health, Inc. | 99.98% |
| Biomerica, Inc. | 98.34% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -32.61 |
| Beta (5Y) | 1.151 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 63.71% |
| Historical Sharpe Ratio (5Y) | -0.331 |
| Historical Sortino (5Y) | -0.5855 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 26.79% |